Are Homologous Recombination Deficiency Mutations Relevant in Colorectal Cancer?

J Natl Cancer Inst. 2022 Feb 7;114(2):176-178. doi: 10.1093/jnci/djab170.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Colorectal Neoplasms* / drug therapy
  • Colorectal Neoplasms* / genetics
  • Homologous Recombination
  • Humans
  • Mutation
  • Poly(ADP-ribose) Polymerase Inhibitors* / therapeutic use

Substances

  • Poly(ADP-ribose) Polymerase Inhibitors